A Double-blind, Randomized, Placebo-controlled Study to Determine the Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia in Midlife Women
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 14 Jan 2019 Planned End Date changed from 1 Feb 2019 to 31 Dec 2019.
- 14 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 31 Dec 2019.
- 22 May 2017 Status changed from not yet recruiting to recruiting.